ORAR III study investigators say that a bare metal stent (BMS) plus oral sirolimus provides a comparable, cost-effective alternative to a drug-eluting stent

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1604, 2007-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus: Stent thrombosis in a patient with a drug-eluting and bare-metal stent?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1214, 2008-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent favourable vs bare-metal stent in STEMI

By  

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior to bare-metal stent in MI

By  

Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Sirolimus: Drug-eluting stent restenosis and thrombosis in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

Sirolimus: Late restenosis following drug-eluting stent placement: case report

By  

Reactions Weekly, Vol. 1, Iss. 1146-1147, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite